Cardiometabolic index and central adiposity as non-invasive markers of hepatic steatosis and elevated liver stiffness in chronic hepatitis B
Background and Aim: Residual liver disease in chronic hepatitis B (CHB) under long-term antiviral therapy is increasingly metabolic. We assessed whether the cardiometabolic in-dex (CMI), modified CMI (MCMI) and simple anthropometry are associated with hepatic steatosis and elevated liver stiffness. Materials and Metho...